期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

新型细胞保护剂——氨磷汀 被引量：11

New-spectrum cytoprotector:amifostine
下载PDF
导出
摘要 氨磷汀是第 1个被认可的广谱细胞保护药 ,就氨磷汀的药动学、作用机制 ,及在肿瘤放。 Amifostine is the first confirmed cytoprotector of broad-spectrum. The article recommends amifostine including its pharmacokinetics, the mechanism of action, and clinical use in radiotherapy and chemotherapy of tumours.
作者 东星月 李晓冰 杜红光 汪运山
机构地区 济南市中心医院药学部 山东省医学科学院研教中心 济南市中心医院中心实验室
出处 《肿瘤防治杂志》 2004年第8期888-890,共3页 China Journal of Cancer Prevention and Treatment
关键词 肿瘤/放射疗法 肿瘤/药物疗法 氨磷汀/药理学 细胞保护/药物作用 综述文献 neoplasms/radiotherapy neoplasms/drug therapy amifostine/pharmacology cytoprotection/drug effects review literature
分类号 R979.1 [医药卫生—药品]
  • 相关文献

参考文献17

  • 1崔慧娟,张树军,李佩文,管忠震,孙晓菲,沈铿,吴明,胡小电,刘淑俊,邸立军,张树才.阿米福汀保护肾脏的疗效观察[J].中华肿瘤杂志,2002,24(1):48-50. 被引量：27
  • 2高怡瑾.化/放疗病人的细胞保护剂──氨磷汀[J].国外医学（儿科学分册）,2000,27(5):266-267. 被引量：13
  • 3周敏,孙载阳,陈宝安.氨磷汀对骨髓造血细胞的保护作用[J].国外医学（输血及血液学分册）,2001,24(2):128-130. 被引量：10
  • 4Glover D,Glick J H,Weiler C,et al. WR-2721 protects against the hematologic toxicity of cyclophosphamide:a controlled phase Ⅱ trial[J]. J Clin Oncol, 1986,4(4):584-588.
  • 5Kemp G, Rose P, Vurain J, et al. Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities results of a randomized control trial in patiets with advanced ovarian cancer [J]. J Clin Oncol, 1996, 14(7):2101-2112.
  • 6Illiano A, Barlettae,De Marino V, et al. New triplet chemotherapy combination with carboplatin, paclitaxel and gemcitabine plus amifostine support in advanced non small cell lung cancer: a phase Ⅱ study[J]. Anticancer Res, 2000,20(5C):3999-4003.
  • 7Genviesse I , Lange C, Schanz J, et al. Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy a comparative study[J].Anticancer Drugs,2001,12(4):345-349.
  • 8Bohuslavizki K H, Klutmann S, Bleckmann C,et al . Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer [J]. Strahlenther Onkol,1999,75(2):57-59.
  • 9Bourhis J,De Crevoisier R, Abdulkarin B,et al Arandomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma[J]. Int J Radiat Oncol Biol Phys, 2000,45(5):1105-1108.
  • 10Buntael J,Kuttner K,Frohlich D,et al . Sclective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer[J] . Ann Oncol, 1998, 9(5):471-473.

二级参考文献46

  • 1刘晓晴,宋三泰,郭军华,胡良平,胡斌,宋梅花,陈建魁,鲍云华.乳腺癌病人高剂量顺铂治疗的肾毒性监测指标比较[J].中华肿瘤防治杂志,1994,10(3):215-218. 被引量：3
  • 2VIKRAM B. Phase Ⅲ randomized trial of amifostine as a radioprotector in head and neck cancer[J]. Clin Oncol, 2001, 19(4) : 1233-1234.
  • 3CAPIZZI RL. Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects [ J ].Semin Oncol, 1999, 26(2 Suppl 7):72-81.
  • 4RYAN SV, CARRITHERS SL, PARKINSON SJ, et al. Hypotensive mechanisms of amifostine[J]. J CIin Pharmacol, 1996,36(4) :365-373.
  • 5VAIRA M, BARONE R, AGHEMO B, et al. Renal protection with amifostine during intraoperative peritoneal chemohyperthermia(IPCH) with cisplatin (CDDP) for peritoneal carcinosis, phase 1 study[J]. Minerva Med, 2001, 92(4) :207-211.
  • 6List AF,Ruth H,Betty G, et al. Semin Oncol, 1996,23(suppl 8):58
  • 7Pierelli L,Scambia G,Fattorossi A et al .Br J Canner,1998,78:1024
  • 8Shpall EJ,Stemmer SM,Hami L,et al. Blood,1994,83:3132
  • 9Cagnoni PJ,Jones RB,Bearman SI,et al. Semin Oncol,1996,23(suppl 8) :44
  • 10Green D. Cancer Res, 1994,53:738

共引文献68

同被引文献89

引证文献11

二级引证文献27

肿瘤防治杂志
2004年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部